Covid19NCT04659473
Spanish Survey on Third Wave of COVID-19
An observational study of Covid19, run by University of Salamanca at 1 site in Spain.
Trial summary
Due to the pandemic situation, a rapid online survey may be the best method to assess and track people's pandemic cooping. Regarding the huge media influence and the government's restrictions to control the spread of covid-19; it is needed to know more about people's perception and situation to conduct future… Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Covid19
- What is being tested?
- Online survey
- How many people
- 1,000 participants
- Where
- 1 siteSpain
- Study dates
- 9 Dec 2020to 20 Dec 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The sample was selected from the Spanish community population
Who may be able to join
- Owning online connection
- Ability to answer and complete the survey
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
Spain1 site
Universidad de Salamanca
Salamanca, 37007
Inés Llamas-Ramos, Doctor, +34 630 720 990, inesllamas@usal.es
Beatriz M Bermejo-Gil, Professor
About this study
Official title: COVID-19, the Third Wave Update People Coping With the COVID-19. A Cross-sectional Online Spanish Survey
Due to the pandemic situation, a rapid online survey may be the best method to assess and track people's pandemic cooping. Regarding the huge media influence and the government's restrictions to control the spread of covid-19; it is needed to know more about people's perception and situation to conduct future contentions plans. This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic. The survey will be delivered to 1000 participants to obtain a representative sample. It would be divided into six sections (general information, demography data, social and consuming habits, Covi-19 question, questions for Covid-19 positive, and questions for Covid-19 negative).
- Conditions
- Covid19
- Being tested
- Online survey
- Keywords
- COVID-19, Epidemiology, Signs and Symptoms, Spain, Rapid online survey
- Medical subject headings
- COVID-19, Signs and Symptoms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Online surveyOther
This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic.
What is being measured
The primary outcome is the main question the study is designed to answer.
What's your work or study system nowadays?
Multiple choice questionnaire
Measured: 20 seconds
Habits before the Covid-19 pandemic
Likert scale questionnaire
Measured: 60 seconds
Habits in the Covid-19 pandemic
Likert scale questionnaire
Measured: 60 seconds
Personal Covid-19 exposure and disease
Dichotomous options questionnaire
Measured: 10 seconds
Positive Covid-19: tests, diagnosis, symptoms and quarantine
Multiple choice questionnaire
Measured: 60 seconds
Negative Covid-19: tests and quarantine
Multiple choice questionnaire
Measured: 40 seconds
Expectations
Multiple choice questionnaire
Measured: 10 seconds
Secondary outcomes (10)
Date of birth
It is registered in the survey to know the age
Measured: 20 seconds
Sex
It is registered in the survey
Measured: 20 seconds
Height
It is registered in centimeters
Measured: 20 seconds
Weight
It is registered in kilograms
Measured: 20 seconds
Blood type
Multiple choice questionnaire
Measured: 20 seconds
Pathologic history
Multiple choice questionnaire
Measured: 20 seconds
Region of residence
Multiple choice questionnaire
Measured: 20 seconds
City of residence
Multiple choice questionnaire
Measured: 20 seconds
Rural or urban environment
Dichotomous options questionnaire
Measured: 20 seconds
Cohabitants in the family unit
The number of cohabitants is registered in the survey
Measured: 20 seconds
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Dec 2020
- Study start9 Dec 2020 (estimated)
- Primary completion20 Dec 2020 (estimated)
- Study completion20 Dec 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Covid19Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Salamanca
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Beatriz-María Bermejo-Gil, University of Salamanca
- Investigators
- Beatriz M Bermejo-Gil, Professor, Principal investigator, University of Salamanca
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04659473
- Sponsor's protocol ID
- CovidSal01/2020
- Status last verified
- Dec 2020
- First submitted
- 8 Dec 2020
- Last updated
- 14 Dec 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 14 Dec 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COVID-19, the Third Wave Update People Coping With the COVID-19. A Cross-sectional Online Spanish Survey
- ClinicalTrials.gov ID
- NCT04659473
- Acronym / sponsor ID
- CovidSal01/2020
- Conditions
- Covid19
- Keywords
- COVID-19, Epidemiology, Signs and Symptoms, Spain, Rapid online survey
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- University of SalamancaUniversity, hospital or other
- Study start
- 9 Dec 2020 (estimated)
- Primary completion
- 20 Dec 2020 (estimated)
- Study completion
- 20 Dec 2020 (estimated)
- First posted
- 9 Dec 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Due to the pandemic situation, a rapid online survey may be the best method to assess and track people's pandemic cooping. Regarding the huge media influence and the government's restrictions to control the spread of covid-19; it is needed to know more about people's perception and situation to conduct future contentions plans. This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic. The survey will be delivered to 1000 participants to obtain a representative sample. It would be divided into six sections (general information, demography data, social and consuming habits, Covi-19 question, questions for Covid-19 positive, and questions for Covid-19 negative).
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The sample was selected from the Spanish community population
Key inclusion criteria (2 listed)
- Owning online connection
- Ability to answer and complete the survey
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Online surveyThis study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic. | Other | – |
Primary outcome
What's your work or study system nowadays?
Time frame: 20 seconds
Multiple choice questionnaire
Habits before the Covid-19 pandemic
Time frame: 60 seconds
Likert scale questionnaire
Habits in the Covid-19 pandemic
Time frame: 60 seconds
Likert scale questionnaire
Personal Covid-19 exposure and disease
Time frame: 10 seconds
Dichotomous options questionnaire
Positive Covid-19: tests, diagnosis, symptoms and quarantine
Time frame: 60 seconds
Multiple choice questionnaire
Negative Covid-19: tests and quarantine
Time frame: 40 seconds
Multiple choice questionnaire
Expectations
Time frame: 10 seconds
Multiple choice questionnaire
10 secondary outcomes
Date of birth
Time frame: 20 seconds
Sex
Time frame: 20 seconds
Height
Time frame: 20 seconds
Weight
Time frame: 20 seconds
Blood type
Time frame: 20 seconds
Pathologic history
Time frame: 20 seconds
Region of residence
Time frame: 20 seconds
City of residence
Time frame: 20 seconds
Rural or urban environment
Time frame: 20 seconds
Cohabitants in the family unit
Time frame: 20 seconds
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Dec 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Covid19
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Beatriz M Bermejo-Gil, Professor principal investigator
University of Salamanca
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Covid19, run by University of Salamanca at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Beatriz M Bermejo-Gil, Professor (+34 622 289 468, beatriz.bermejo@usal.es), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
What's your work or study system nowadays? (time frame: 20 seconds). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2020.